1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Pseudohypoaldosteronism: new trials by email Literature Review of Pseudohypoaldosteronism trials Research Report on Pseudohypoaldosteronism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lokelma for RAAS Maximisation in CKD & Heart Failure. Lokelma Oral Product - Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction | Phase 3 | Completed | St George's, University of London | 112 | 2022-01-19 | 2026-04-27 |
Acute Kidney Injury (1) · Hyperkalemia (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Renal Tubular Transport, Inborn Errors (1) · Urogenital Diseases (1)
St George's, University of London (1)
United Kingdom (1)